VanEck Biotech ETF (BBH) Holdings → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free BBH Stock Alerts $164.06 -0.56 (-0.34%) (As of 05/10/2024 ET) Add Compare Share Share HoldingsStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestSocial MediaStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestSocial Media Top 26 BBH HoldingsRankCompanyCurrent PriceWeightShares Held1AMGNAmgen$310.15-0.9%15.02%229,3012VRTXVertex Pharmaceuticals$422.78+0.9%9.32%99,0403REGNRegeneron Pharmaceuticals$973.80+0.6%7.81%35,3904GILDGilead Sciences$65.96+2.1%7.45%484,5685MRNAModerna$117.31-4.4%6.54%221,4666ARGXargenx$374.63-2.1%4.57%49,403 Get the Latest News and Ratings for BBH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for VanEck Biotech ETF and its competitors with MarketBeat's FREE daily newsletter. 7BIIBBiogen$221.50-0.6%4.51%89,8748IQVIQVIA$234.08+2.1%4.49%85,8849ILMNIllumina$110.53-0.7%4.17%143,11010ICLRICON Public$315.39+0.1%4.13%58,26111BGNEBeiGene$161.13-4.5%3.28%86,01012NBIXNeurocrine Biosciences$136.70-2.1%2.80%85,13913BMRNBioMarin Pharmaceutical$81.03-0.8%2.76%140,18914SRPTSarepta Therapeutics$131.82-0.4%2.53%82,41715CRLCharles River Laboratories International$228.12-0.9%2.44%45,09016TECHBio-Techne$80.91+1.7%2.42%136,26217NTRANatera$105.29+10.2%2.37%107,40018BNTXBioNTech$91.67-0.4%2.26%104,37119QGENQiagen$43.61+0.1%2.00%199,13420EXASExact Sciences$53.51-1.2%1.98%138,96721ALNYAlnylam Pharmaceuticals$150.47-0.6%1.96%55,29822INCYIncyte$53.06-0.8%1.77%141,55123RGENRepligen$166.81+1.2%1.72%43,95124CRSPCRISPR Therapeutics$51.17-4.4%0.89%68,68425CYTKCytokinetics$62.10-3.0%0.86%56,82126Us DollarN/A-0.04%175,811 Geographic ExposureUnited States93.0%Ireland4.2%Switzerland0.8%Currency ExposureUSD100.1%Sector ExposureHealth Care95.8%Industry ExposureBiotechnology74.1%Health Care Providers & Services13.8%Health Care Equipment & Supplies7.9%SubIndustry ExposureBiotechnology69.9%Health Care Services13.8%Life Sciences Tools & Services7.9% Related Companies and Tools Related Companies: PPH Portfolio PSCH Portfolio PTH Portfolio BIB Portfolio BTEC Portfolio IBBQ Portfolio FTXH Portfolio MEDX Portfolio JDOC Portfolio BIS Portfolio This page (NASDAQ:BBH) was last updated on 5/12/2024 by MarketBeat.com Staff From Our PartnersThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaShocking: One AI startup's revenue could surge 4,735%Manward Press[Webinar] A Deep Dive into Options Volatility: Skew & Relative ValueOICMissed NVDA? Buy this AI stock NOWChaikin AnalyticsYou need to know these two things about AI stocks ASAP…InvestorPlaceGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VanEck Biotech ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
